GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Amphastar Pharmaceuticals
Amphastar is a pharmaceutical company specializing in complex injectable and inhaled drugs. Its stock price reflects its ability to develop and manufacture hard-to-copy products, such as generic epinephrine and naloxone nasal spray.
Share prices of companies in the market segment - Pharma other
Amphastar is a pharmaceutical company specializing in complex injectable and inhalation drugs. This is its core segment. We classify it in the Pharma Other sector, and the chart below reflects the dynamics of the entire hard-to-copy drug industry.
Broad Market Index - GURU.Markets
Amphastar Pharmaceuticals is a specialty pharmaceutical company that develops, manufactures, and markets injectable and inhaled medications. It is a component of the GURU.Markets index. The chart below represents the market. See how Amphastar shares compare to the pharmaceutical sector.
Change in the price of a company, segment, and market as a whole per day
AMPH - Daily change in the company's share price Amphastar Pharmaceuticals
Daily fluctuations at Amphastar, a pharmaceutical company specializing in injectables, reflect manufacturing complexity and regulatory risks. Change_co shows sensitivity to FDA approvals. This metric is key to analyzing the generics and biosimilars sector on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Pharma other
Amphastar Pharmaceuticals, Inc. is a pharmaceutical company. This chart highlights the sector's high volatility. Comparing it to AMPH, which focuses on injectable and inhaled drugs, helps assess its unique risk profile in this niche.
Daily change in the price of a broad market stock, index - GURU.Markets
Amphastar is a pharmaceutical company specializing in injectable and inhaled medications. The pharmaceutical sector may operate by its own rules, but stocks of such companies are still subject to overall market trends. The chart below provides context for assessing Amphastar's performance.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Amphastar Pharmaceuticals
Amphastar is a pharmaceutical company specializing in generic and specialty drugs. Its year-over-year performance reflects a complex process of acquisition integration and its strategy of focusing on the most profitable segments.
Annual dynamics of market capitalization of the market segment - Pharma other
Amphastar Pharmaceuticals, Inc. is a pharmaceutical company specializing in the development and production of complex injectable and inhaled drugs. The chart shows how its expertise in this technologically complex niche and diversified portfolio contribute to its stable growth.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Amphastar, a manufacturer of generic and specialty drugs, operates in the defensive healthcare sector. However, its stock price reflects not only stable demand but also intense competition and pricing pressure. The chart tells the story of the struggle for profitability in the challenging pharmaceutical sector.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Amphastar Pharmaceuticals
The value of Amphastar, a manufacturer of specialty pharmaceuticals, depends on its product cycle. The monthly fluctuations on the chart reflect sales data for its injectables and progress in obtaining FDA approvals for new, complex generics and biosimilars.
Monthly dynamics of market capitalization of the market segment - Pharma other
Amphastar Pharmaceuticals, Inc. is a pharmaceutical company specializing in the development and production of injectable and inhaled drugs, which are often complex to manufacture. The dynamics of its sector, shown in the chart, serve as background. It is interesting to assess how technical expertise in the production of complex generics and biosimilars creates a competitive advantage for Amphastar.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Amphastar Pharmaceuticals is a pharmaceutical company specializing in complex injectable and inhaled drugs, often generics. Its business model is less risky than that of developers of new molecules. A chart of the overall market performance allows us to assess how much investors value this more stable model, which may make Amphastar shares less volatile.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Amphastar Pharmaceuticals
Amphastar Pharmaceuticals, a manufacturer of complex injectable and inhaled medications, including generic and branded products, whose weekly stock performance reflects news of new drug approvals and competition in the generic market, creating a volatile profile.
Weekly dynamics of market capitalization of the market segment - Pharma other
Amphastar, a manufacturer of complex generics, is part of the pharmaceutical sector. The chart compares its performance with the industry to see how much of its weekly fluctuations are driven by general pharma regulatory news and how much by product-specific approvals.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Amphastar Pharmaceuticals is a pharmaceutical company specializing in injectable and inhaled medications. This chart will help you assess how AMPH shares are performing relative to the market. Is its business defensive due to drug demand, or does its product mix make it more volatile?
Market capitalization of the company, segment and market as a whole
AMPH - Market capitalization of the company Amphastar Pharmaceuticals
The Amphastar Pharmaceuticals chart is a financial map of complex-to-manufacture drugs. The market capitalization of this company, which specializes in generic injectable and inhaled medications, reflects its ability to overcome significant technological and regulatory barriers. Its dynamics are a barometer of its success in producing hard-to-manufacture drugs.
AMPH - Share of the company's market capitalization Amphastar Pharmaceuticals within the market segment - Pharma other
Amphastar Pharmaceuticals is a specialty pharmaceutical company that develops and manufactures complex generic injectable and inhalation medications. Its market share reflects its technological expertise in hard-to-reach niches. The chart shows its market share in markets where manufacturing complexity is a barrier to entry.
Market capitalization of the market segment - Pharma other
Amphastar Pharmaceuticals specializes in the production of complex injectable and inhalation drugs. The chart below shows the overall market capitalization of the entire pharmaceutical industry. Its dynamics provide the backdrop against which Amphastar occupies its niche, which requires high technological expertise.
Market capitalization of all companies included in a broad market index - GURU.Markets
Amphastar is a pharmaceutical company specializing in complex injectable and inhaled medications commonly used in hospitals. Its market capitalization chart tells the story of niche yet critically important drugs, demonstrating how technical expertise in manufacturing creates a competitive advantage.
Book value capitalization of the company, segment and market as a whole
AMPH - Book value capitalization of the company Amphastar Pharmaceuticals
Amphastar Pharmaceuticals' book value is derived from its injectable drug manufacturing plants. The chart below shows how the company manages its complex manufacturing base. Its growth reflects investments in capacity expansion and compliance with strict regulatory standards.
AMPH - Share of the company's book capitalization Amphastar Pharmaceuticals within the market segment - Pharma other
Amphastar is a pharmaceutical company specializing in complex injectable drugs. Their production requires unique and technologically advanced manufacturing facilities. The asset share chart shows how the company is investing in creating this sophisticated physical infrastructure, which is its competitive advantage.
Market segment balance sheet capitalization - Pharma other
Amphastar Pharmaceuticals develops and manufactures injectable and inhalation medications. The production of such complex drugs requires specialized and certified manufacturing facilities. The book value chart illustrates the capital intensity of its vertically integrated pharmaceutical company model.
Book value of all companies included in the broad market index - GURU.Markets
Amphastar's book value represents a vertically integrated pharmaceutical powerhouse. The company's assets include not only R&D laboratories but also its own manufacturing plants for complex injectables and active pharmaceutical ingredients. The chart illustrates the scale of this manufacturing base, which ensures quality control from molecule to packaging.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Amphastar Pharmaceuticals
Amphastar Pharmaceuticals develops and manufactures injectable and inhalation medications, often challenging to manufacture as generics. Its book value reflects its production capacity, while its market capitalization reflects a premium for its technical expertise and ability to bring difficult-to-copy drugs to market.
Market to book capitalization ratio in a market segment - Pharma other
Amphastar Pharmaceuticals develops and manufactures injectable and inhalation medications, often challenging to produce generic versions. The company owns manufacturing facilities. The chart shows the market premium for its technical expertise and product portfolio over the book value of its manufacturing plants.
Market to book capitalization ratio for the market as a whole
Amphastar Pharmaceuticals develops and manufactures injectable and inhaled medications, often difficult to produce generic versions. The company combines scientific research (intangible assets) with manufacturing capabilities (tangible assets). The chart shows how the market values this hybrid model, which can generate stable revenue.
Debts of the company, segment and market as a whole
AMPH - Company debts Amphastar Pharmaceuticals
Amphastar Pharmaceuticals, a manufacturer of complex injectables, uses debt to fund research and vertical integration. This chart may reflect investments in the development of difficult-to-manufacture generics and biosimilars, as well as in building its own manufacturing facilities to control the entire supply chain.
Market segment debts - Pharma other
Amphastar Pharmaceuticals develops and manufactures injectable and inhaled medications, including generic and brand-name drugs. In the pharmaceutical industry, debt can be used to fund research, production capacity expansion, and litigation. The chart shows how the company manages its financial risks in this complex industry.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Amphastar Pharmaceuticals
Amphastar Pharmaceuticals develops and manufactures injectable and inhalation medications, including generic and brand-name drugs. Pharmaceutical production requires significant investment in manufacturing facilities and adherence to quality standards. This chart shows how the company finances its operations and development, allowing one to assess its financial stability.
Market segment debt to market segment book capitalization - Pharma other
Amphastar Pharmaceuticals develops and manufactures injectable and inhaled generic and brand-name drugs. Manufacturing such complex medications requires specialized technological equipment. This chart shows the overall debt burden in the pharmaceutical industry. It helps understand how Amphastar finances its production facilities and R&D.
Debt to book value of all companies in the market
Amphastar, a manufacturer of complex generic drugs, operates in the defensive healthcare sector. This chart shows the overall debt load of the economy. It helps assess the extent to which the company's business is unaffected by macroeconomic cycles. Demand for its drugs is likely to remain stable even during periods when overall debt in the economy rises.
P/E of the company, segment and market as a whole
P/E - Amphastar Pharmaceuticals
Amphastar Pharmaceuticals develops and manufactures injectable and inhaled generic and proprietary drugs. This chart shows how investors view its complex manufacturing process and product portfolio. This indicator's performance depends on the successful launch of new generics and the continued supply of existing hospital medications.
P/E of the market segment - Pharma other
Amphastar Pharmaceuticals operates in the complex generics sector. This chart shows the average price-to-earnings ratio (P/E) for the pharmaceutical industry. Comparing the company's P/E to this ratio helps understand whether the market considers its ability to produce complex injectables and obtain regulatory approvals more valuable than that of other pharmaceutical companies.
P/E of the market as a whole
Amphastar Pharmaceuticals develops and manufactures injectable and inhalation drugs, often challenging to produce generic versions. Its success depends on new product approvals and manufacturing capacity. This chart shows the overall sentiment in the pharmaceutical sector. It helps us understand whether Amphastar's valuation is the result of successful launches of complex drugs or is simply following general trends.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Amphastar Pharmaceuticals
Amphastar Pharmaceuticals develops, manufactures, and markets injectable, inhaled, and intranasal generic and brand-name drugs. This chart shows market expectations regarding the approval and launch of new, complex drugs. Future profits depend on the successful launch of products requiring complex manufacturing processes.
%20P%2FE%20Amphastar%20Pharmaceuticals&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Amphastar-Pharmaceuticals&v=1772619158029 "Chart of the company's future (projected) P/E Amphastar Pharmaceuticals")
Future (projected) P/E of the market segment - Pharma other
Amphastar Pharmaceuticals develops and manufactures injectable and inhalation medications, often complex generics and biosimilars. This chart shows how the market views its future profitability relative to the pharmaceutical sector. It reflects investor confidence in its manufacturing capabilities and ability to successfully bring complex products to market.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Pharma-other&v=1772619158127 "Future (projected) P/E graph of the market segment - Pharma other")
Future (projected) P/E of the market as a whole
Amphastar Pharmaceuticals develops and manufactures injectable and inhaled generic and branded medications, often for hospital use. Demand for its products is stable, but overall market conditions, as shown in this chart, influence government healthcare budgets and pricing policies, which may impact the company's long-term profitability.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772619158160 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Amphastar Pharmaceuticals
Amphastar Pharmaceuticals develops, manufactures, and markets injectable and inhaled generic and brand-name drugs. The company's profitability depends on the successful launch of new products and competition in the generic market. This chart illustrates the company's ability to obtain FDA approvals and manage its manufacturing process to achieve financial goals.
Profit of companies in the market segment - Pharma other
Amphastar Pharmaceuticals develops, manufactures, and markets complex injectable and inhalation medications, often technically challenging generics. This graph, showing overall revenue in the pharmaceutical sector, reflects the importance of niche products. Amphastar's ability to successfully manufacture and obtain approval for such complex medications directly impacts its share and profitability in the segment.
Overall market profit
Amphastar Pharmaceuticals develops and manufactures injectable and inhalation medications, often challenging to manufacture as generic versions. The company occupies a niche where competition is lower and demand is stable. This allows it to demonstrate sustainable growth, less dependent on general economic cycles but requiring a high level of scientific and manufacturing expertise.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Amphastar Pharmaceuticals
Amphastar Pharmaceuticals develops, manufactures, and markets injectable and inhaled generic and brand-name medications. This chart displays analysts' forecasts for future profits, which are dependent on new product approvals and competition in the generics market. Expectations are based on the potential of its product portfolio.
%20profit%20of%20the%20company%20Amphastar%20Pharmaceuticals&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Amphastar-Pharmaceuticals&v=1772619158359 "Graph of future (projected) profit of the company Amphastar Pharmaceuticals")
Future (predicted) profit of companies in the market segment - Pharma other
Amphastar Pharmaceuticals develops and manufactures injectable and inhalation generics, as well as branded drugs. This chart shows future profit forecasts for the entire pharmaceutical sector. It allows one to assess how the company's business model, which combines the stability of generics with the potential of its own developments, compares to overall industry trends.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Pharma-other&v=1772619158416 "Graph of future (predicted) profits of companies in a market segment - Pharma other")
Future (predicted) profit of the market as a whole
Amphastar Pharmaceuticals develops and manufactures injectable and inhalation medications, often difficult to produce generically. Demand for its products is stable and driven by the needs of the healthcare system. However, overall economic conditions, as reflected in the chart, can impact pricing pressure from customers (hospitals and distributors) and the company's profitability.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772619158429 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Amphastar Pharmaceuticals
Amphastar Pharmaceuticals develops, manufactures, and markets injectable and inhaled generic and brand-name drugs. This multiple, which links market value to sales, reflects the valuation of its diversified portfolio. It shows how investors assess the stability of its generic business and the potential for new, more complex product development.
P/S market segment - Pharma other
Amphastar Pharmaceuticals develops, manufactures, and markets injectable and inhaled generic and proprietary drugs, many of which are technologically complex to manufacture. The company occupies a significant niche in the pharmaceutical market. This chart shows how the market averages value revenue in the generics sector, providing insight into how investors value Amphastar's manufacturing expertise and product portfolio.
P/S of the market as a whole
Amphastar Pharmaceuticals is a specialty pharmaceutical company that develops and manufactures injectable, inhaled, and intranasal medications, many of which are technologically complex to manufacture. This chart helps investors compare the niche pharmaceutical company's revenue valuation with general market multiples.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Amphastar Pharmaceuticals
Amphastar Pharmaceuticals develops, manufactures, and markets injectable and inhaled generic and brand-name medications. This chart shows how the market values the company based on its projected future sales. It reflects expectations for the successful launch of new products and stable demand for its existing portfolio.
%20P%2FS%20Amphastar%20Pharmaceuticals&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Amphastar-Pharmaceuticals&v=1772619158636 "The graph of the company's future (projected) P/S Amphastar Pharmaceuticals")
Future (projected) P/S of the market segment - Pharma other
Amphastar Pharmaceuticals develops, manufactures, and markets injectable and inhalation generics, as well as proprietary drugs that are often complex to manufacture. The chart compares the company's estimated future sales with the pharmaceutical sector. A forward estimate may indicate confidence in its manufacturing capabilities and the successful launch of new products.
%20P%2FS%20market%20segment%20graph%20-%20Pharma%20other&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Pharma-other&v=1772619158651 "Future (projected) P/S market segment graph - Pharma other")
Future (projected) P/S of the market as a whole
Amphastar Pharmaceuticals develops and manufactures injectable and inhalation medications, including generic and branded products. The company's success depends on the approval of new drugs and competition in the generic market. This graph of investor expectations reflects their outlook on the pharmaceutical sector, particularly its more stable and predictable segment.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772619158679 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Amphastar Pharmaceuticals
Amphastar Pharmaceuticals' revenue is generated in the complex hospital drug segment. The company specializes in the production and sale of injectable and inhaled medications, often generic or complex to manufacture. The growth in this chart reflects its ability to successfully compete and bring in-demand medical products to market.
Sales of companies in the market segment - Pharma other
Amphastar Pharmaceuticals develops, manufactures, and markets complex injectable and inhaled generic and proprietary drugs. The company specializes in products that are difficult to manufacture. This chart represents the total revenue of the entire specialty pharmaceuticals market, highlighting the niche in which Amphastar successfully competes.
Overall market sales
Amphastar Pharmaceuticals develops, manufactures, and markets injectable and inhalation medications, often difficult to produce generic versions. Demand for its products is determined by the needs of the healthcare system. This demand, reflecting the overall economic situation, impacts the budgets of hospitals and government programs, which are the primary buyers of Amphastar products.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Amphastar Pharmaceuticals
Amphastar Pharmaceuticals develops, manufactures, and markets injectable and inhaled generic and brand-name drugs. Its success depends on new product approvals and competition in the generic drug market. This chart shows analyst expectations for sales of key drugs and new product launches in its portfolio.
%20sales%20of%20the%20company%20Amphastar%20Pharmaceuticals&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Amphastar-Pharmaceuticals&v=1772619158789 "Schedule of future (projected) sales of the company Amphastar Pharmaceuticals")
Future (projected) sales of companies in the market segment - Pharma other
Amphastar Pharmaceuticals develops, manufactures, and markets injectable and inhaled generic and brand-name medications. This chart segments projected sales by key products, such as glucagon and enoxaparin. This allows us to assess which drugs, according to analysts, will be the company's primary revenue drivers in the near future.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Pharma-other&v=1772619158853 "Schedule of future (projected) sales of companies in the market segment - Pharma other")
Future (projected) sales of the market as a whole
Generic and specialty pharmaceutical market forecasts, which are part of the overall expectations in this chart, are important for Amphastar Pharmaceuticals. The company develops and manufactures injectable medications. Its success depends on the stability of the healthcare system and budgetary allocations for pharmaceuticals.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772619158876 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Amphastar Pharmaceuticals
Amphastar Pharmaceuticals develops, manufactures, and markets complex injectable and inhaled medications, both branded and generic. This chart shows the profitability of its diversified pharmaceutical portfolio. Profitability depends on successful sales of key products, manufacturing efficiency, and the ability to secure approvals for new, complex medications.
Market segment marginality - Pharma other
Amphastar Pharmaceuticals develops, manufactures, and markets injectable and inhaled generic and proprietary drugs, often complex to manufacture. The company's profitability depends on its ability to secure approvals for these complex products. This chart shows the average profitability in the pharmaceutical industry, helping to assess the success of Amphastar's niche strategy.
Market marginality as a whole
Amphastar Pharmaceuticals develops and manufactures injectable and inhalation medications, often difficult to produce generic versions of. The company's success depends on the expiration of patents on its original drugs and its ability to obtain regulatory approval. This graph, reflecting the overall state of the economy, indirectly impacts the healthcare system and drug pricing pressure.
Employees in the company, segment and market as a whole
Number of employees in the company Amphastar Pharmaceuticals
Amphastar Pharmaceuticals develops and manufactures injectable and inhalation medications, often challenging to produce generic versions. This chart reflects the size of its team of scientists, engineers, and manufacturing personnel. Growth in the chart may be due to expansion of production capacity or new product development, which requires significant scientific and technical expertise.
Share of the company's employees Amphastar Pharmaceuticals within the market segment - Pharma other
Amphastar Pharmaceuticals develops, manufactures, and markets injectable and inhalation medications, often challenging to manufacture as generic versions. This chart shows the company's share of the total workforce in its pharmaceutical niche. This reflects its manufacturing expertise and ability to bring complex and critically important drugs to market.
Number of employees in the market segment - Pharma other
Amphastar Pharmaceuticals is a pharmaceutical company specializing in the development, production, and marketing of injectable, inhaled, and intranasal medications. The chart illustrates employment in the pharmaceutical industry. The growing number of specialists in this sector demonstrates the ongoing demand for new and complex dosage forms, which is Amphastar's core competency.
Number of employees in the market as a whole
Amphastar Pharmaceuticals develops and manufactures injectable and inhalation medications, often challenging to manufacture as generics. Their growth depends on successful development and FDA approvals. This overall employment schedule has little impact on their specific business. The key driver of hiring is expansion of their product portfolio and manufacturing capacity.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Amphastar Pharmaceuticals (AMPH)
Amphastar Pharmaceuticals develops and manufactures injectable and inhalation medications. The company combines complex manufacturing processes with research and development. This metric reflects the balance between the value of its product portfolio and the need for a large staff to ensure sterile manufacturing and quality control.
%20of%20the%20company%20Amphastar%20Pharmaceuticals%20(AMPH)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Amphastar-Pharmaceuticals-AMPH&v=1772619159227 "Chart of market capitalization per employee (in thousands of dollars) of the company Amphastar Pharmaceuticals (AMPH)")
Market capitalization per employee (in thousands of dollars) in the market segment - Pharma other
Amphastar Pharmaceuticals is a pharmaceutical company specializing in injectable and inhaled medications, often complex generics (such as the Lovenox analog). They combine R&D with in-house manufacturing. This indicator helps assess how the market values their complex drug business.
%20by%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Pharma-other&v=1772619159242 "Market capitalization per employee (in thousands of dollars) by market segment - Pharma other")
Market capitalization per employee (in thousands of dollars) for the overall market
Amphastar Pharmaceuticals develops, manufactures, and markets injectable and inhalation medications, often challenging to produce generic versions. This business requires high scientific and manufacturing expertise. This chart shows how the market evaluates the company's ability to operate in a complex pharmaceutical niche, where every employee contributes to the creation of a high-tech product.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772619159277 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Amphastar Pharmaceuticals (AMPH)
Amphastar is a pharmaceutical company specializing in the development and production of complex injectable and inhalation drugs (often complex generics or proprietary products). This chart shows their performance in a niche market where manufacturing and R&D require high levels of expertise: how profitably they produce these technologically complex drugs.
%20Chart%20Amphastar%20Pharmaceuticals%20(AMPH)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Amphastar-Pharmaceuticals-AMPH&v=1772619159307 "Company Profit Per Employee (in thousands of dollars) Chart Amphastar Pharmaceuticals (AMPH)")
Profit per employee (in thousands of dollars) in the market segment - Pharma other
Amphastar is a "hybrid" pharmaceutical company. They "manufacture" complex (difficult-to-make) "generics" (injectables) and "R&D" (new drugs). This graph shows the benchmark for the "Pharmaceutical Sector." In this "B2B manufacturing" sector, the benchmark is moderate. Profit per employee is generated by the "technological" "complexity" of "manufacturing" (high barrier), not by "R&D."
%20in%20the%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Pharma-other&v=1772619159342 "Chart of profit per employee (in thousands of dollars) in the market segment - Pharma other")
Profit per employee (in thousands of dollars) for the market as a whole
Amphastar Pharmaceuticals is a specialty pharmaceutical company. They focus on complex generics (such as injectables) and proprietary products that are difficult to manufacture, often for the hospital market. This is a knowledge-intensive production process. This chart helps understand how niche pharmaceuticals, which require R&D and complex manufacturing, compare in terms of staff efficiency.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772619159376 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Amphastar Pharmaceuticals (AMPH)
Amphastar Pharmaceuticals develops, manufactures, and markets injectable and inhalation medications, often challenging to manufacture as generics. Revenue per employee reflects both production efficiency and R&D success. The graph shows how successfully the company brings complex products to market and competes in its niche.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Amphastar-Pharmaceuticals-AMPH&v=1772619159389 "Sales chart per company employee Amphastar Pharmaceuticals (AMPH)")
Sales per employee in the market segment - Pharma other
Amphastar is a pharmaceutical company specializing in complex generics and biosimilars that are difficult to manufacture (such as injectables). They are also known for their overdose-relief nasal spray. This chart shows how effective their manufacturing facilities and R&D team are in producing and commercializing these complex drugs.
Sales per employee for the market as a whole
Amphastar Pharmaceuticals (AMPH) is a biopharmaceutical company specializing in the development, production, and marketing of complex injectable and inhaled drugs (e.g., generics that are difficult to manufacture). This chart reflects their model. AMPH's success depends on their manufacturing expertise (R&D and manufacturing under one roof), which allows them to enter niche markets with high margins.
Short shares by company, segment and market as a whole
Shares shorted by company Amphastar Pharmaceuticals (AMPH)
Amphastar Pharmaceuticals specializes in the development and production of injectable and inhaled generics (analogs) and complex drugs that are difficult to copy (e.g., adrenaline, glucagon). This chart shows the level of skepticism. Bears may fear increased competition in the generic segment, leading to lower prices, or delays in FDA approval of new drugs.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Amphastar-Pharmaceuticals-AMPH&v=1772619159518 "Short Shares Chart for the Company Amphastar Pharmaceuticals (AMPH)")
Shares shorted by market segment - Pharma other
Amphastar (AMPH) is a biopharmaceutical company specializing in complex generics and injectables, including naloxone (an overdose treatment). This chart shows bets against the generics sector. If investors are short this sector, they expect increased pricing pressure on generics and regulatory challenges in approving complex drugs.
Shares shorted by the overall market
Amphastar (AMPH) is a generic and niche drug manufacturer. This Short_All chart shows systemic pessimism. When it rises, even "defensive" sectors like healthcare are sold off. This fear of a correction is weighing on AMPH, despite the stability of its business.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Amphastar Pharmaceuticals (AMPH)
Amphastar Pharmaceuticals produces injectable generic and brand-name drugs. This chart helps assess stock momentum. A reading above 70 may be caused by new drug approval, strong sales, or shortages at competitors. Oversold levels (<30) often reflect concerns about pricing pressure on generics, R&D setbacks, or regulatory issues.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Amphastar-Pharmaceuticals-AMPH&v=1772619159709 "RSI 14 indicator chart for the company's stock Amphastar Pharmaceuticals (AMPH)")
RSI 14 Market Segment - Pharma other
Amphastar Pharmaceuticals is a specialty pharmaceutical company focused on the development and production of complex injectable and inhaled medications (both generic and brand). This chart shows the overall sentiment in the specialty pharmaceutical sector. It helps us understand whether AMPH's price movement is driven by news about its specific products or is a general "wave" across the industry.
RSI 14 for the overall market
Amphastar (AMPH), a maker of generic injectables, is often "sheltered" from this chart. Demand for its products (for example, in hospitals) isn't affected by euphoria or panic. During times of panic, investors may even seek safe havens in companies with stable medical demand that aren't correlated with the economic cycle.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast AMPH (Amphastar Pharmaceuticals)
Amphastar is a pharmaceutical company specializing in the development and production of complex injectable and inhaled generic drugs. This chart shows the average analyst forecast. Their targets are based on the approval of new complex generics and the commercial success of branded products, such as BAQSIMI.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-AMPH-Amphastar-Pharmaceuticals&v=1772619159857 "A chart showing analyst consensus forecasts for the expected stock price. AMPH (Amphastar Pharmaceuticals)")
The difference between the consensus estimate and the actual stock price AMPH (Amphastar Pharmaceuticals)
Amphastar (AMPH) is a pharmaceutical company specializing in complex generics (injectables, inhalers) and branded drugs that are difficult to copy. This chart shows their R&D assessment. It measures the gap between the price and the consensus target, reflecting the potential analysts see in their portfolio of complex drugs.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-AMPH-Amphastar-Pharmaceuticals&v=1772619159990 "A chart showing the difference between the consensus forecast and the actual stock price. AMPH (Amphastar Pharmaceuticals)")
Analyst consensus forecast for stock prices by market segment - Pharma other
Amphastar Pharmaceuticals is a specialty pharmaceutical company that produces complex generics and proprietary drugs, often in injectable or inhaled forms (e.g., naloxone). This chart shows analysts' overall expectations for the pharmaceutical sector. It reflects whether experts believe in the niche strategy for complex drugs.
Analysts' consensus forecast for the overall market share price
Amphastar (AMPH) is a niche generic. They specialize in complex generics (injectables, inhalers) and biosimilars. This chart, reflecting expert expectations, influences them. During a recession (pessimism), healthcare systems put pressure on prices but are more actively switching to cheaper generics (good for AMPH).
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Amphastar Pharmaceuticals
Amphastar is a specialty pharmaceutical company. They focus on complex products: injectables, inhalers, and biosimilars (such as their version of insulin). This chart is an indicator of their manufacturing prowess. It likely reflects their ability to secure FDA approval for these complex generics and their commercialization success.
AKIMA Market Segment Index - Pharma other
Amphastar (AMPH) is a specialized pharmaceutical company focused on the development and production of complex injectable and inhaled generics (e.g., glucagon, epinephrine). This aggregate metric evaluates companies. The graph shows the average value for the segment. This benchmark: how does this niche (complex generics) model (AMPH) differentiate it from the average pharmaceutical company?
The AKIM Index for the overall market
Amphastar is a pharmaceutical company specializing in injectables, inhalers, and insulin (generics and private labels). This chart, which reflects the market average, provides a macro backdrop. It helps assess how Amphastar, operating in a complex manufacturing niche, compares to overall economic trends in healthcare.
